Appendix 2

Public hearings

Wednesday, 29 January 2020
Edinburgh Room
Stamford Plaza Hotel
United in Compassion Ltd
Mrs Lucy Haslam, Director
Multiple Sclerosis Australia
Mr Andrew Giles, National Policy Officer
MS Research Australia
Dr Tennille Luker, Research Development Coordinator
Epilepsy Action Australia
Ms Carol Ireland, Chief Executive Officer and Managing Director
Australian Lawyers Alliance
Dr Teresa Nicoletti, Member; Partner, Mills Oakley; and Director, Medical Cannabis Council
Mr Michael Balderstone, President, Nimbin HEMP Embassy
Ms Lyn Cleaver, Private capacity
Lambert Initiative for Cannabinoid Therapeutics, University of Sydney
Professor Iain McGregor, Academic Director
Associate Professor Jonathon Arnold, Deputy Academic Director
Australian Medical Association
Dr Tony Bartone, President
Royal Australian College of General Practitioners
Dr Harry Nespolon, President
Clinical Oncology Society of Australia
Dr David Speakman, Expert Advisor
NICM Health Research Institute (Western Sydney University)
Mr Justin Sinclair, Research Fellow
Australasian College of Nutritional and Environmental Medicine
Professor Kylie O'Brien, Member
National Institute of Integrative Medicine
Professor Avni Sali, Founding Director
Dr Tamara Nation, General Practitioner
Professor Ian Brighthope, Board Member; and Founder, ACNEM
Pharmaceutical Society of Australia
Mr Jarrod McMaugh, Project Pharmacist
Mr John Jackson, President, Victorian Branch
Pharmacy Guild of Australia
Mr Anthony Tassone, National Councillor
Medicines Australia
Mrs Elizabeth de Somer, Chief Executive Officer
Dr Vicki Gardiner, Director, Policy and Research
Canopy Growth Corporation (Spectrum Therapeutics)
Dr Christina Xinos, Medical Director, Australia and New Zealand
Medicinal Cannabis Industry Australia
Mr Peter Crock, Chairman
Ms Elisabetta Faenza, Director
Tasmanian Alkaloids
Dr Ross Murdoch, Chief Executive Officer
Dr Les Baxter, Director, Agricultural R and D
Department of Health
Adjunct Professor John Skerritt, Deputy Secretary
Mr George Masri, Assistant Secretary, Regulatory Services and Drug Control Branch
Dr Grant Pegg, Assistant Secretary, Pharmacovigilance and Special Access Branch

 |  Contents  |